116 related articles for article (PubMed ID: 9322887)
1. Interleukin-10 in non-Hodgkin's lymphoma.
Cortes J; Kurzrock R
Leuk Lymphoma; 1997 Jul; 26(3-4):251-9. PubMed ID: 9322887
[TBL] [Abstract][Full Text] [Related]
2. Serum interleukin-10 in non-Hodgkin's lymphoma: a prognostic factor.
Blay JY; Burdin N; Rousset F; Lenoir G; Biron P; Philip T; Banchereau J; Favrot MC
Blood; 1993 Oct; 82(7):2169-74. PubMed ID: 8400266
[TBL] [Abstract][Full Text] [Related]
3. Serum interleukin 6 levels are elevated in lymphoma patients and correlate with survival in advanced Hodgkin's disease and with B symptoms.
Kurzrock R; Redman J; Cabanillas F; Jones D; Rothberg J; Talpaz M
Cancer Res; 1993 May; 53(9):2118-22. PubMed ID: 8481913
[TBL] [Abstract][Full Text] [Related]
4. Serum levels of interleukin-6 and interleukin-10 in Turkish patients with aggressive non-Hodgkin's lymphoma.
Guney N; Soydinc HO; Basaran M; Bavbek S; Derin D; Camlica H; Yasasever V; Topuz E
Asian Pac J Cancer Prev; 2009; 10(4):669-74. PubMed ID: 19827892
[TBL] [Abstract][Full Text] [Related]
5. Th1/Th2 cytokine expression and its relationship with tumor growth in B cell non-Hodgkin's lymphoma (NHL).
Jones EA; Pringle JH; Angel CA; Rees RC
Leuk Lymphoma; 2002 Jun; 43(6):1313-21. PubMed ID: 12153001
[TBL] [Abstract][Full Text] [Related]
6. Human interleukin-10 expression in T/natural killer-cell lymphomas: association with anaplastic large cell lymphomas and nasal natural killer-cell lymphomas.
Boulland ML; Meignin V; Leroy-Viard K; Copie-Bergman C; Brière J; Touitou R; Kanavaros P; Gaulard P
Am J Pathol; 1998 Oct; 153(4):1229-37. PubMed ID: 9777954
[TBL] [Abstract][Full Text] [Related]
7. Human B cell interleukin 10.
Benjamin D; Park CD; Sharma V
Leuk Lymphoma; 1994 Jan; 12(3-4):205-10. PubMed ID: 8167552
[TBL] [Abstract][Full Text] [Related]
8. IL-10 induces the development of immunosuppressive CD14(+)HLA-DR(low/-) monocytes in B-cell non-Hodgkin lymphoma.
Xiu B; Lin Y; Grote DM; Ziesmer SC; Gustafson MP; Maas ML; Zhang Z; Dietz AB; Porrata LF; Novak AJ; Liang AB; Yang ZZ; Ansell SM
Blood Cancer J; 2015 Jul; 5(7):e328. PubMed ID: 26230952
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus infection and associated products (LMP, EBNA2, vIL-10) in nodal non-Hodgkin's lymphoma of human immunodeficiency virus-negative Japanese.
Ohshima K; Suzumiya J; Tasiro K; Mukai Y; Tanaka T; Kato A; Kikuchi M
Am J Hematol; 1996 May; 52(1):21-8. PubMed ID: 8638607
[TBL] [Abstract][Full Text] [Related]
10. The prevalence of Epstein-Barr virus infection in head and neck non-Hodgkin's lymphomas in Khorasan, northeast of Iran.
Abadi RZ; Sistani NS; Mohtasham N; Hesari KK; Vaezi T; Pazouki M; Shakeri MT
J Pak Med Assoc; 2013 Jul; 63(7):882-7. PubMed ID: 23901714
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus-associated extranodal non-Hodgkin's lymphoma of the sinonasal tract and nasopharynx in Thailand.
Mitarnun W; Suwiwat S; Pradutkanchana J
Asian Pac J Cancer Prev; 2006; 7(1):91-4. PubMed ID: 16629523
[TBL] [Abstract][Full Text] [Related]
12. Interleukin (IL)-10 and IL-6 are produced in vivo by non-Hodgkin's lymphoma cells and act as cooperative growth factors.
Voorzanger N; Touitou R; Garcia E; Delecluse HJ; Rousset F; Joab I; Favrot MC; Blay JY
Cancer Res; 1996 Dec; 56(23):5499-505. PubMed ID: 8968107
[TBL] [Abstract][Full Text] [Related]
13. [Differential diagnostic and prognostic value of serum cytokines (soluble CD30, soluble interleukin-2 receptor, interleukin-10 and interleukin-6) in Hodgkin's disease and lymphosarcomas].
Iaguzhinskaia OE; Lazarev IE; Nikitin EA; Samoĭlova RS; Loginova IV; Gemdzhan EG; Novikov VA; Mamiliaeva ZKh; Pivnik AV
Ter Arkh; 2001; 73(4):45-51. PubMed ID: 11494447
[TBL] [Abstract][Full Text] [Related]
14. Serum IL-10 and IL-6 levels at diagnosis as independent predictors of outcome in non-Hodgkin's lymphoma.
el-Far M; Fouda M; Yahya R; el-Baz H
J Physiol Biochem; 2004 Dec; 60(4):253-8. PubMed ID: 15957243
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of interleukin 10 by rituximab results in down-regulation of bcl-2 and sensitization of B-cell non-Hodgkin's lymphoma to apoptosis.
Alas S; Emmanouilides C; Bonavida B
Clin Cancer Res; 2001 Mar; 7(3):709-23. PubMed ID: 11297268
[TBL] [Abstract][Full Text] [Related]
16. Increased serum levels of interleukin-9 correlate to negative prognostic factors in Hodgkin's lymphoma.
Fischer M; Bijman M; Molin D; Cormont F; Uyttenhove C; van Snick J; Sundström C; Enblad G; Nilsson G
Leukemia; 2003 Dec; 17(12):2513-6. PubMed ID: 14562126
[TBL] [Abstract][Full Text] [Related]
17. Changes in the T-helper cell 1/T-helper cell 2 balance of peripheral T-helper cells after autologous peripheral blood stem cell transplantation for non-Hodgkin's lymphoma.
Mukai M; Bohgaki T; Kondo M; Notoya A; Kohno M
Ann Hematol; 2001 Dec; 80(12):715-21. PubMed ID: 11797111
[TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus detection in non-Hodgkin's lymphoma of the oral cavity: an immunocytochemical and in situ hybridization study.
Leong IT; Fernandes BJ; Mock D
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Aug; 92(2):184-93. PubMed ID: 11505266
[TBL] [Abstract][Full Text] [Related]
19. Correlation of serum IL-2, IL-6 and IL-10 levels with International Prognostic Index in patients with aggressive non-Hodgkin's lymphoma.
Aydin F; Yilmaz M; Ozdemir F; Kavgaci H; Yavuz MN; Yavuz AA
Am J Clin Oncol; 2002 Dec; 25(6):570-2. PubMed ID: 12478000
[TBL] [Abstract][Full Text] [Related]
20. Aggressive forms of non-Hodgkin's lymphoma in two patients bearing coinfection of Epstein-Barr and hepatitis C viruses.
Libra M; Gloghini A; De Re V; Rupolo M; Navolanic PM; Gasparotto D; Stivala F; Spina M; Boiocchi M; Carbone A
Int J Oncol; 2005 Apr; 26(4):945-50. PubMed ID: 15753988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]